Serum cytokine levels and the expression of estrogen and progesterone receptors in breast cancer patients

被引:21
作者
Fuksiewicz, Malgorzata
Kaminska, Janina
Kotowicz, Beata
Kowalska, Maria
Rubach, Maryna
Pienkowski, Tadeusz
机构
[1] Maria Sklodowska Curie Mem Canc Ctr, Dept Tumor Markers, PL-02781 Warsaw, Poland
[2] Inst Oncol, PL-02781 Warsaw, Poland
[3] Maria Sklodowska Curie Mem Canc Ctr, Dept Breast Canc & Reconstruct Surg, PL-02781 Warsaw, Poland
关键词
breast cancer; cytokine; estrogen receptor; progesterone receptor;
D O I
10.1515/CCLM.2006.192
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Background: The aim of this study was to assess the correlation between serum concentrations of cytokines and soluble cytokine receptors in breast cancer patients and the expression of estrogen and progesterone receptors in tumor cells. Methods: The study comprised 158 female breast cancer patients before treatment and 50 healthy individuals as a reference group. Results: The study revealed significantly higher concentrations of most cytokines in breast cancer patients compared to the reference group. Assessment of the correlation between cytokine concentrations in serum and the expression of estrogen and progesterone receptors in tumor cells showed significantly higher interleukin-8 (IL-8) concentrations in patients lacking progesterone receptors in comparison to patients with these receptors. The concentrations of cytokines and their soluble receptors as a function of the expression of estrogen and progesterone receptors were also analyzed in two age groups. In younger patients, aged 50 years and below, no significant differences were found between serum cytokine concentrations and the expression of both estrogen and progesterone receptors. In patients older than 50 years, significantly higher IL-8 concentrations were observed in individuals lacking progesterone receptors, whereas IL-1ra was significantly higher in those lacking estrogen receptors. Conclusions: IL-1ra and IL-8 concentrations in serum, together with a lack of estrogen and progesterone receptors in tumor cells, in breast cancer patients older than 50 years could represent additional predictive factors for this disease.
引用
收藏
页码:1092 / 1097
页数:6
相关论文
共 30 条
[1]   Prognostic value of serum levels of interleukin 6 and of serum and plasma levels of vascular endothelial growth factor in hormone-refractory metastatic breast cancer patients [J].
Bachelot, T ;
Ray-Coquard, I ;
Menetrier-Caux, C ;
Rastkha, M ;
Duc, A ;
Blay, JY .
BRITISH JOURNAL OF CANCER, 2003, 88 (11) :1721-1726
[2]  
Balsari A, 1999, LAB INVEST, V79, P897
[3]  
Bouma-ter-Steege JCA, 2004, CLIN CANCER RES, V10, P7171
[4]   Tumour necrosis factor-alpha, interleukin-6, and fasting serum insulin correlate with clinical outcome in metastatic breast cancer patients treated with chemotherapy [J].
Bozcuk, H ;
Uslu, G ;
Samur, M ;
Yildiz, M ;
Özben, T ;
Özdogan, M ;
Artaç, M ;
Altunbas, H ;
Akan, I ;
Savas, B .
CYTOKINE, 2004, 27 (2-3) :58-65
[5]   Different signalling pathways regulate VEGF and IL-8 expression in breast cancer: implications for therapy [J].
Chelouche-Lev, D ;
Miller, CP ;
Tellez, C ;
Ruiz, M ;
Bar-Eli, M ;
Price, JE .
EUROPEAN JOURNAL OF CANCER, 2004, 40 (16) :2509-2518
[6]  
Coskun U, 2003, NEOPLASMA, V50, P41
[7]   An angiogenic switch in breast cancer involves estrogen and soluble vascular endothelial growth factor receptor 1 [J].
Elkin, M ;
Orgel, A ;
Kleinman, HK .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2004, 96 (11) :875-878
[8]   Is adjuvant tamoxifen recommended in post-menopausal node-negative breast cancer patients with high estrogen receptor values? [J].
Floiras, JL ;
Hacene, K ;
Turpin, F ;
Spyratos, F .
INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 2000, 15 (02) :135-138
[9]  
Foekens JA, 2001, CANCER RES, V61, P5407
[10]   Expression of interleukin 6 (IL-6) correlates with oestrogen receptor in human breast carcinoma [J].
Fontanini, G ;
Campani, D ;
Roncella, M ;
Cecchetti, D ;
Calvo, S ;
Toniolo, A ;
Basolo, F .
BRITISH JOURNAL OF CANCER, 1999, 80 (3-4) :579-584